Company intelligence
RxCelerate
Architects of drug discovery and development
About RxCelerate
RxCelerate Limited provides drug discovery and development services across Europe and the USA. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. RxCelerate, including sister companies, RxBiologics and The Cambridge Partnership, offers a complete solution for today’s complex R&D demands. Across small molecules and biologics, with expert scientific execution and back-office support, we keep your asset moving forward. Connect with us to be part of our exciting journey!
Verified activity
Signals from RxCelerate
2 published signals
Presence & Recognition
RxCelerate participated in Day 1 of the NLS Days 2026 conference in Stockholm, Sweden, where attendees can visit booth D20 to speak with Hafeez M. and Amy Warner.
Reported by RxCelerate
People
RxCelerate is targeting permanent Director-level roles in the Cambridge area for Andrew Carr.
Reported by Andrew Carr